Aller au contenu principal
Accès ouvert déclaré 2025 preprint

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries

0Citations signalées — pas une note de qualité
105Institutions déclarées
26Pays d’affiliation déclarés

Résumé fourni par la source

ABSTRACT Background Breast cancer is multifactorial. Focusing on limited risk factors may miss high-risk individuals. Methods We assessed the performance and overlap of various risk factors in identifying high-risk individuals for invasive breast cancer (BrCa) and ductal carcinoma in situ (DCIS) in 161,849 European-ancestry and 18,549 Asian-ancestry women. Discriminatory ability was evaluated using the area under the receiver operating characteristic curve (AUC). High-risk criteria included: 5-year absolute risk ≥1·66% by the Gail model [GAIL binary ]; first-degree family history of breast cancer [FH binary ]; 5-year absolute risk ≥1·66% by a 313-variants polygenic risk score [PRS binary ]; and carriers of pathogenic variants in breast cancer predisposition genes [PTV binary ]. Findings The 5-year absolute risk by PRS outperformed the Gail model in predicting BrCa (Europeans vs controls : AUC PRS =0·635 [0·632-0·638] vs AUC Gail =0·492 [0·489-0·495]; Asians vs controls : AUC PRS =0·564 [0·556-0·573] vs AUC Gail =0·506 [0·497-0·514]). PRS binary and GAIL binary identified more high-risk European than Asia individuals. High-risk proportions were higher among BrCa (16-26%) and DCIS (20-33%) compared to controls (9-15%) among young Europeans and all Asians. Fewer than 7% of BrCa, 10% of DCIS, and 3% of controls were classified as high-risk by multiple risk classifiers. Overlap between PRS binary and PTV binary was minimal (<0·65% Europeans, <0·15% Asians) compared to the proportion at high risk using PTV binary alone (Europeans: 4·6%, Asians: 4·4%) and PRS binary alone (Europeans: 13·9%, Asians: 8·5%). PRS binary and FH binary uniquely identified 5-6% and 9-11% of young BrCa, respectively. Interpretation The incomplete overlap between high-risk individuals identified by PRS binary , GAIL binary , FH binary, and PTV binary highlights the need for a comprehensive approach to breast cancer risk prediction. SIGNIFICANCE This study shows that different ways of predicting breast cancer risk do not always flag the same people, suggesting that combining multiple risk factors could improve early detection and screening.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Overlap of high-risk individuals across family history, genetic &amp; non-genetic breast cancer risk models: Analysis of 180,398 women from European &amp; Asian ancestries
Date Crossref
03/03/2025
Éditeur
openRxiv
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Agency for Science, Technology and ResearchNational University of SingaporeNational University Health SystemGenome Institute of SingaporeDepartment of Health and Human ServicesUniversity of TorontoLunenfeld-Tanenbaum Research InstituteN.N. Alexandrov National Cancer CentreQueen's UniversityLund UniversityGerman Cancer Research CenterHeidelberg UniversityAmerican Cancer SocietyMedizinische Hochschule HannoverUniversity of CambridgeCancer Research UKHarvard UniversityManchester Academic Health Science CentreHuntsman Cancer InstituteInstituto de Investigación Sanitaria de SantiagoIntermountain HealthcareUniversität HamburgUniversity Medical Center Hamburg-EppendorfUniversity Cancer Center HamburgQIMR Berghofer Medical Research InstituteSeoul National UniversityCancer Research InstituteNew Generation University CollegeSeoul National University HospitalKarolinska InstitutetFox Chase Cancer CenterVIB-KU Leuven Center for Cancer BiologyKU LeuvenBrigham and Women's HospitalLeipzig University of Applied SciencesLife UniversityLeipzig UniversitySt Mary's HospitalBreast Cancer NowCurtin UniversityNew Mexico Cancer CenterColumbia UniversityErasmus MCStockholm South General HospitalHong Kong Sanatorium and HospitalUniversity of Nottingham Malaysia CampusCancer Research MalaysiaErasmus MC Cancer InstituteDr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyUniversity of TübingenUniversity of ManchesterCancer Research UK Manchester InstituteAichi Cancer CenterNational Cancer CenterNational Cancer Research InstitutePomeranian Medical UniversityStanford Health CareNagoya UniversityStanford UniversityInternational Hereditary Cancer CenterUniversity of Saint MarySt. Mary's HospitalThe Catholic University of Korea Seoul St. Mary's HospitalStanford MedicineNational Cancer InstituteJohanniter-Krankenhaus BonnCenter for Human GeneticsUniversity of Hong KongUppsala UniversityNational Institute of OncologyThe Maria Sklodowska-Curie National Research Institute of OncologyThe University of MelbourneMonash HealthMelbourne HealthMonash UniversityKarolinska University HospitalUniversity of Eastern FinlandFondazione IRCCS Istituto Nazionale dei TumoriCancer Council VictoriaKuopio University HospitalEastern Finland Laboratory CenterUniversity of MalayaUniversity of British ColumbiaCyprus Institute of Neurology and GeneticsNational Institute of Environmental Health SciencesBC Cancer AgencyUniversity of ChicagoIFOMMacedonian Academy of Sciences and ArtsUniversity of OuluTechnion – Israel Institute of TechnologyUniversity of ThessalyNordLabShaukat Khanum Memorial Cancer Hospital and Research CenterKing's College LondonLondon CancerMayo Clinic in FloridaVanderbilt UniversityClalit Health ServicesCentre hospitalier universitaire de QuébecMelbourne ClinicThe University of Western AustraliaPontificia Universidad JaverianaSubang Jaya Medical CentreNational Cancer Centre Singapore

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

BRCA gene mutations in cancerGlobal Cancer Incidence and ScreeningGenetic factors in colorectal cancer

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.